Overview 1
Catalyst 1
Summary 1
Table of Contents 2
Table of figures 3
Table of tables 4
Company Structure 5
Company Overview and Key Facts 5
Business Description 6
Landmark Products and Services 6
Picoplatin 6
History 7
Locations and Subsidiaries 8
Company Financials 9
Stock Market Performance 9
P&L 11
Balance Sheet 14
Cash Flow 14
Products & Services 15
Pipeline Products 15
In-house Pipeline 15
Picoplatin 15
AC Forecast Product Sales 16
Competitors and Strategic Business Relationships 17
Key Competitors 17
Key Suppliers 17
Shareholding Structure 18
Strategy 19
Company View 19
Corporate Strategy 22
SWOT Analysis 23
Overview 23
Strengths 24
Picoplatin for small cell lung cancer 24
Weaknesses 25
Discontinued product candidates 25
Termination of agreement with Janssen Pharmaceutica 25
Opportunities 26
Market for anti-cancer drugs 26
Threats 27
Uncertainty in the coverage and reimbursement status 27
Lengthy and expensive regulatory process 27
Value Chain Analysis 28
Overview 28
Discovery and Product Development 28
Scorecard 29
Overview 29
Scorecard Analysis 29
Key Employees 30
List of Key Employees 30
Key Employee Biographies 31
Jerry McMahon 31
Ronald A Martell 31
Robert S Basso 32
Frederick B Craves 32
E Rolland Dickson 33
Carl S Goldfischer 33
Robert M Littauer 34
Nicholas J Simon 34
David R Stevens 35
Caroline M Loewy 35
Robert De Jager 36
David A Karlin 36
Cheni Kwok 37
Anna Lewak Wight 37
Financial and Operational Overview 38
Financial and Operational Overview 38
APPENDIX 40
Ask the analyst 40
Datamonitor consulting 40
Disclaimer 40
List of Tables
Table 1: Poniard - Key Facts 5
Table 2: Poniard - Locations and Subsidiaries 8
Table 3: Poniard - Year-End Share Price and Market Capitalization, 2002-2006 ($) 9
Table 4: Poniard - Key Events Impacting Share Price Performance 10
Table 5: Poniard - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 11
Table 6: Poniard - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 13
Table 7: Poniard - Balance Sheet, 2002-2006 ($ Mn) 14
Table 8: Poniard - Cash Flow, 2002-2006 ($ Mn) 14
Table 9: Poniard - In-house Pipeline Products 15
Table 10: Poniard - Forecast Sales, 2006-2010 ($ Mn) 16
Table 11: Poniard - Key Competitors 17
Table 12: Poniard - Key Suppliers 17
Table 13: Poniard - Key Shareholders 18
Table 14: Poniard - SWOT Analysis Summary 23
Table 15: Poniard - Value Chain Analysis 28
Table 16: Poniard - Key Employees 30
Table 17: Poniard - Financial and Operational Overview 38
List of Figures
Figure 1: Poniard - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 12